IR Live
UPCOMING
Recurring Webinar
Based on the publication of the Interim Report earlier the same day, the senior Management Team will offer a walkthrough of the report contents and answer questions from the audience.
The Example Company does not really exist and is only made up ...
The Example Company does not really exist and is only made up ...
On-demand
-
Tuesday, May 17, 2022 · 2:00 PM CESTCopenhagen, Denmark, 6 May 2022 – FluoGuide A/S (“FluoGuide” or the “Company”) invites to a presentation of the results from the clinical trial of FG001 used to guide surgery in patients with aggressive high-grade glioma brain cancer, which will f... -
Monday, March 14, 2022 · 11:00 AM CETThe company's management will present the outcome of the directed issue announced on March 10:
Copenhagen, Denmark, 17:31 CEST, 10 March 2022 – FluoGuide A/S (publ), a developer of surgical precision solutions within oncology (“FluoGuide” or the ... -
-
Monday, October 11, 2021 · 9:30 AM CESTFG001 is proven safe in patients undergoing surgery for cancer – a significant milestone for FluoGuide to further advance clinical development in aggressive brain cancer and in a prevalent indication.
This investor call will allow investors to l...
Past
